review

Just how transformative will AI/ML be for immuno-oncology?
Daniel Bottomly, Shannon McWeeney

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e007841; DOI: 10.1136/jitc-2023-007841
iRECIST and atypical patterns of response to immuno-oncology drugs
Jorge Luis Ramon-Patino, Sabine Schmid, Sally Lau, Lesley Seymour, Pierre-Olivier Gaudreau, Janice Juan Ning Li, Penelope Ann Bradbury, Emiliano Calvo

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004849; DOI: 10.1136/jitc-2022-004849
Corticosteroid-resistant immune-related adverse events: a systematic review
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e007409; DOI: 10.1136/jitc-2023-007409
Gasdermin-mediated pyroptosis confers anticancer immunity
Wu Lin, Ben Lin, Quan Zhou, Lisong Teng

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008162; DOI: 10.1136/jitc-2023-008162
Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis
Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Runhao Li, Jun Li, Paul Drew, Timothy Price, Eric Smith, Guy J Maddern, Kevin Aaron Fenix

Journal for ImmunoTherapy of Cancer Apr 2023, 11 (4) e006764; DOI: 10.1136/jitc-2023-006764
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
Solange Peters, Luis Paz-Ares, Roy S Herbst, Martin Reck

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004863; DOI: 10.1136/jitc-2022-004863
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan, Anna Mondino

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004147; DOI: 10.1136/jitc-2021-004147
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition
Meagan-Helen Henderson Berg, Sonia Victoria del Rincón, Wilson H Miller

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003551; DOI: 10.1136/jitc-2021-003551
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
Olivier Michielin, Aly-Khan Lalani, Caroline Robert, Padmanee Sharma, Solange Peters

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003024; DOI: 10.1136/jitc-2021-003024
Targeting Cbl-b in cancer immunotherapy
Ryan C. Augustin, Riyue Bao, Jason J. Luke

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006007; DOI: 10.1136/jitc-2022-006007

Main menu

review

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

review

Pages